These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 8490781
1. Early patency in acute myocardial infarction. Belenkie I. Can J Cardiol; 1993 Mar; 9(2):149-51. PubMed ID: 8490781 [No Abstract] [Full Text] [Related]
2. "Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction. White HD, Cross DB, Williams BF, Norris RM, Woo KS, Hamer AW, Elliott JM, Ormiston JA. Am J Cardiol; 1995 Jan 15; 75(2):172-4. PubMed ID: 7810496 [No Abstract] [Full Text] [Related]
4. Long term effects of thrombolytic therapy in acute myocardial infarction. Shah LS. J Assoc Physicians India; 1994 Jan 15; 42(1):9-11. PubMed ID: 7836276 [No Abstract] [Full Text] [Related]
8. [The prevention of reocclusion after thrombolysis in acute myocardial infarct: is tissue-type plasminogen activator really superior to streptokinase?]. Negrini M. G Ital Cardiol; 1995 Apr 15; 25(4):511-5. PubMed ID: 7677921 [No Abstract] [Full Text] [Related]
9. [Are the publicized advantages of thrombolytic treatment of myocardial infarct with recombinant t-PA (ACTILYSE) in comparison with streptokinase so decisive, that despite the high cost a general use of ACTILYSE is justified?]. Gulba DC. Internist (Berl); 1992 May 15; 33(5):364-5. PubMed ID: 1612871 [No Abstract] [Full Text] [Related]
10. What you should know about thrombolytic therapy for acute MI. Aragon D, Martin M. Am J Nurs; 1993 Sep 15; 93(9):24-31; quiz 33. PubMed ID: 8213959 [No Abstract] [Full Text] [Related]